Skip Nav Destination
Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state
Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study: Presented in part at the meeting of the International Society of Thrombosis and Haemostasis in Washington, DC, August 1999.
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome
Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells
Issue Archive
January 15 2002
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
REVIEW ARTICLES
CHEMOKINES
Interleukin-10 modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite effects on stromal cell–derived factor-1 and B-lymphocyte chemoattractant
Karl Balabanian,Arnaud Foussat,Laurence Bouchet-Delbos,Jacques Couderc,Roman Krzysiek,Ali Amara,Françoise Baleux,Alain Portier,Pierre Galanaud,Dominique Emilie
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state
Clinical Trials & Observations
Silvia Buonamici,Emanuela Ottaviani,Nicoletta Testoni,Vittorio Montefusco,Giuseppe Visani,Francesca Bonifazi,Marilina Amabile,Carolina Terragna,Deborah Ruggeri,Pier Paolo Piccaluga,Alessandro Isidori,Michele Malagola,Michele Baccarani,Sante Tura,Giovanni Martinelli
Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study: Presented in part at the meeting of the International Society of Thrombosis and Haemostasis in Washington, DC, August 1999.
Clinical Trials & Observations
Pier M. Mannucci,Juan Chediak,Wahid Hanna,John Byrnes,Marlies Ledford,Bruce M. Ewenstein,Anastassios D. Retzios,Barbara A. Kapelan,Richard S. Schwartz,Craig Kessler,the Alphanate Study Group
GENE THERAPY
HEMATOPOIESIS
Differential gene expression profiling of adult murine hematopoietic stem cells
In-Kyung Park,Yaqin He,Fangming Lin,Ole D. Laerum,Qiang Tian,Roger Bumgarner,Christopher A. Klug,Kaijun Li,Christian Kuhr,Michelle J. Doyle,Tao Xie,Michèl Schummer,Yu Sun,Adam Goldsmith,Michael F. Clarke,Irving L. Weissman,Leroy Hood,Linheng Li
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
NEOPLASIA
P-glycoprotein–actin association through ERM family proteins: a role in P-glycoprotein function in human cells of lymphoid origin
Francesca Luciani,Agnese Molinari,Francesco Lozupone,Annarica Calcabrini,Luana Lugini,Annarita Stringaro,Patrizia Puddu,Giuseppe Arancia,Maurizio Cianfriglia,Stefano Fais
Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro
Benjamin M. F. Mow,Joya Chandra,Phyllis A. Svingen,Christopher G. Hallgren,Ellen Weisberg,Timothy J. Kottke,Ven L. Narayanan,Mark R. Litzow,James D. Griffin,Edward A. Sausville,Ayalew Tefferi,Scott H. Kaufmann
PHAGOCYTES
TRANSPLANTATION
Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin
Stanislaw M. Stepkowski,Rebecca A. Erwin-Cohen,Fariba Behbod,Mou-Er Wang,Xienui Qu,Neelam Tejpal,Zsuzsanna S. Nagy,Barry D. Kahan,Robert A. Kirken
BRIEF REPORTS
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome
Clinical Trials & Observations
Brief Report
Elizabeth M. Kang,Moniek de Witte,Harry Malech,Richard A. Morgan,Sheila Phang,Charles Carter,Susan F. Leitman,Richard Childs,A. John Barrett,Richard Little,John F. Tisdale
Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells
Brief Report
James A. L. Fenton,Jan-Willem Vaandrager,Wilhelmina M. Aarts,Richard J. Bende,Karel Heering,Martin van Dijk,Gareth Morgan,Carel J. M. van Noesel,Ed Schuuring,Philip M. Kluin
CORRESPONDENCE
Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus–infected patients treated for non-Hodgkin lymphoma
Marcello Persico,Fedele De Marino,Giovanni Di Giacomo Russo,Alessandro Severino,Bruno Palmentieri,Marco Picardi,Aristide Morante,Bruno Rotoli,Roberto Torella,Amalia De Renzo
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals